Anthem Biosciences Limited has informed the Exchange regarding 'Intimation of violation under Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons as required under SEBI (Prohibition of Insider Trading) Regulations 2015 ( SEBI PIT Regulations )'.
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Anthem Biosciences has informed NSE about a violation of its internal Code of Conduct framed under SEBI's Prohibition of Insider Trading (PIT) Regulations, 2015. The violation was committed by a 'designated person' — an employee or insider covered under the company's insider trading policy. No details of the nature of the violation, the person involved, or any penalty imposed by SEBI have been disclosed. This is a mandatory disclosure required by listed companies when a code violation is identified. The company is required to report the incident, and SEBI may take further action if the violation is material.
For retail shareholders, this is a compliance-related disclosure and not necessarily negative for the stock. However, repeated or serious insider trading violations can attract SEBI penalties, market bans, or damage to the company's governance reputation. Investors should watch for any follow-up filings clarifying the severity of the violation or any SEBI action.